| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,372 |
15,839 |
$1.05M |
| 99199 |
Unlisted special service, procedure or report |
87,882 |
55,846 |
$358K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,818 |
1,339 |
$228K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,898 |
2,296 |
$195K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,120 |
844 |
$119K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
800 |
684 |
$67K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,321 |
2,708 |
$58K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
861 |
683 |
$28K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
268 |
214 |
$24K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
275 |
261 |
$22K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
625 |
470 |
$16K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
170 |
138 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
703 |
334 |
$9K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
216 |
176 |
$8K |
| 99051 |
|
302 |
256 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
75 |
71 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
479 |
424 |
$4K |
| 96127 |
|
886 |
764 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
126 |
110 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
52 |
37 |
$3K |
| 90686 |
|
823 |
740 |
$2K |
| 92552 |
|
649 |
540 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
46 |
39 |
$2K |
| 87430 |
|
92 |
89 |
$1K |
| 0072A |
|
19 |
14 |
$1K |
| 87631 |
|
15 |
13 |
$1K |
| 0071A |
|
26 |
17 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
12 |
12 |
$972.63 |
| 0124A |
|
19 |
12 |
$852.18 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
98 |
85 |
$685.93 |
| D0145 |
Oral evaluation for a patient under three years of age |
19 |
19 |
$621.90 |
| 81003 |
|
347 |
231 |
$601.66 |
| 90651 |
|
21 |
18 |
$420.48 |
| 99173 |
|
1,603 |
1,339 |
$413.37 |
| D1206 |
Topical application of fluoride varnish |
18 |
18 |
$274.50 |
| 81025 |
|
52 |
34 |
$246.20 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
18 |
13 |
$212.92 |
| 90656 |
|
13 |
12 |
$97.75 |
| 3074F |
|
150 |
132 |
$0.00 |
| 90647 |
|
21 |
12 |
$0.00 |
| 91307 |
|
38 |
22 |
$0.00 |
| 3079F |
|
28 |
25 |
$0.00 |
| 3078F |
|
154 |
137 |
$0.00 |
| 90670 |
|
53 |
41 |
$0.00 |
| 99072 |
|
37 |
37 |
$0.00 |
| 90633 |
|
13 |
13 |
$0.00 |
| 91300 |
|
24 |
17 |
$0.00 |
| 90685 |
|
17 |
12 |
$0.00 |